Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications.
Sign Up to like & getrecommendations! Published in 2019 at "Joint Commission journal on quality and patient safety"
DOI: 10.1016/j.jcjq.2018.12.003
Abstract: OBJECTIVES New specialty drugs such as biologics are now available in record numbers, presenting increased safety risks for people with immune-mediated diseases. However, comprehensive assessments of patient safety for these drugs are lacking. We examined… read more here.
Keywords: specialty; safety; patient safety; specialty medications ... See more keywords